Clinical Trials

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

2,000 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Phase 2 Active not recruiting

20 enrolled

DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT07133490 2026-06-01

INTERACT Stomach-II

Phase 2 Recruiting

55 enrolled

Phase NA Not yet recruiting

Stomach Neoplasms

NCT07615907 2026-05-29

PAPGC

20 enrolled

Stomach Neoplasms

NCT07605312 2026-05-28

AI-Based Risk Prediction Model for Upper Digestive Tract Cancer

10,000 enrolled

Esophageal Neoplasms, Gastritis, Atrophic, Stomach Neoplasms

NCT07607119 2026-05-28

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

53 enrolled

Phase EARLY_PHASE1 Recruiting

Stomach Neoplasms

NCT05955833 2026-05-27

HER Image

Phase NA Completed

6 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT06937567 2026-05-26

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

36 enrolled

Biliary Tract Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms

NCT07180966 2026-05-26

SAH

Completed

780 enrolled

Postoperative Complications, Stomach Neoplasms, Microsatellite Instability

NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

EndocrineGastrointestinalNET

200 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT07593820 2026-05-22

Catherine

Phase 1 Recruiting

15 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT07603349 2026-05-22

Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2/3 Not yet recruiting

405 enrolled

Stomach Neoplasms

NCT07604857 2026-05-22

BRIDGE-GC

Phase NA Completed

55 enrolled

Hyperphagia, Stomach Neoplasms

NCT06768164 2026-05-20

BYQoL-GC

Phase 3 Recruiting

250 enrolled

Neoplasms, Stomach Neoplasms

NCT07581730 2026-05-20

A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases

107 enrolled

Phase 2 Not yet recruiting

Liver Neoplasms, Stomach Neoplasms

NCT07595523 2026-05-20

Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair Deficiency

30 enrolled

Stomach Neoplasms

NCT07600125 2026-05-20

Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers

5,000 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT07488611 2026-05-19

PROGAIN

Phase 3 Recruiting

110 enrolled

Hyperphagia, Stomach Neoplasms

NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

171 enrolled

Phase NA Not yet recruiting

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

NCT07596732 2026-05-19

SUNRISE

120 enrolled

GastrointestinalThoracic

Colonic Neoplasms, Disease, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT01514045 2026-05-18

The Gastric Cancer Foundation: A Gastric Cancer Registry

500 enrolled

Phase NA Active not recruiting

Stomach Neoplasms

NCT06157216 2026-05-18

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

65 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Stomach Neoplasms

NCT06904365 2026-05-18

OvAR-Y

Active not recruiting

10 enrolled

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Uterine Neoplasms

NCT07592338 2026-05-18

KITuKo

Completed

30 enrolled

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05698992 2026-05-15

Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

100 enrolled

Phase 2 Active not recruiting

Esophageal Neoplasms, Stomach Neoplasms

NCT06251973 2026-05-15

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

20 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT06580574 2026-05-15

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Phase 2 Recruiting

34 enrolled

Colonic Neoplasms, Stomach Neoplasms

NCT07401199 2026-05-15

Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

2,000 enrolled

Phase 2/3 Active not recruiting

Stomach Neoplasms

NCT07241715 2026-05-14

CONVERGENCE

300 enrolled

Stomach Neoplasms

NCT07586384 2026-05-14

Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial

90 enrolled

Stomach Neoplasms

NCT07587229 2026-05-14

Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer

329 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Stomach Neoplasms

NCT06673329 2026-05-13

Brodalumab in the Treatment of Immune-Related Adverse Events

Phase 1 Recruiting

11 enrolled

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms

NCT07511894 2026-05-12

BBNIGC

Phase 2 Not yet recruiting

33 enrolled

Phase 2 Not yet recruiting

Stomach Neoplasms

NCT07581405 2026-05-12

GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer

26 enrolled

Stomach Neoplasms

NCT06788548 2026-05-11

FLECSS

312 enrolled

Stomach Neoplasms

NCT07283939 2026-05-11

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

420 enrolled

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04736485 2026-05-08

GASPAR

Phase 2 Completed

67 enrolled 10 charts

BreastGastrointestinalGynecologicHead & NeckThoracic

Stomach Neoplasms

NCT06380816 2026-05-08

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Phase 1/2 Recruiting

167 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06828588 2026-05-08

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Phase EARLY_PHASE1 Recruiting

30 enrolled

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT07574957 2026-05-08

PREDIPER

300 enrolled

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07000253 2026-05-07

OMEC-5

Phase 2/3 Recruiting

290 enrolled